Jefferies Remains Positive on Neurocrine Bio. (NBIX) and NBI-98854 Despite Problems With Phase 2 Study Site
Go back to Jefferies Remains Positive on Neurocrine Bio. (NBIX) and NBI-98854 Despite Problems With Phase 2 Study Site| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 152.57 -0.36 (0.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $152.93 | 52 Week High | $58.46 | |||
| Open | $153.13 | 52 Week Low | $31.25 | |||
| Day High | $155.27 | P/E | N/A | |||
| Day Low | $152.51 | EPS | $-0.69 | |||
| Volume | 1,227,622 | |||||
